Implantation of a neoantigen-targeted hydrogel vaccine prevents recurrence of pancreatic adenocarcinoma after incomplete resection.
Delitto D, Zabransky DJ, Chen F, Thompson ED, Zimmerman JW, Armstrong TD, Leatherman JM, Suri R, Lopez-Vidal TY, Huff AL, Lyman MR, Guinn SR, Baretti M, Kagohara LT, Ho WJ, Azad NS, Burns WR, He J, Wolfgang CL, Burkhart RA, Zheng L, Yarchoan M, Zaidi N, Jaffee EM.
Delitto D, et al. Among authors: zheng l.
Oncoimmunology. 2021 Nov 8;10(1):2001159. doi: 10.1080/2162402X.2021.2001159. eCollection 2021.
Oncoimmunology. 2021.
PMID: 34777919
Free PMC article.